Business Context and Reporting Period
This Form 8-K was filed by NanoVibronix, Inc. (not Envue Medical, Inc.) on November 3, 2017, reporting events occurring on November 1, 2017. The Company is an emerging growth company incorporated in Delaware with principal executive offices in Nesher, Israel.
Key Financial Metrics and Capital Structure
The filing details a specific capital raising event rather than periodic financial performance metrics.
- Offering Size: 1,224,488 shares of common stock (or equivalents) and warrants to purchase up to 918,366 shares.
- Offering Price: $4.90 per share of common stock (or equivalent).
- Warrant Terms: One five-year warrant per share sold to purchase 0.75 of a share at an exercise price of $6.95.
- Expected Proceeds: Approximately $5.1 million, net of underwriting discounts and estimated offering expenses.
- Liquidity Impact: Proceeds are intended to fund operations and working capital, though specific pre-offering cash balances are not disclosed in this text.
Material Changes
The primary material change is the transition of the Company's common stock to the NASDAQ Capital Market. Trading under the ticker symbol "NAOV" commenced on November 2, 2017. The offering is expected to close on or about November 6, 2017, subject to customary closing conditions.
Outlook, Risks, and Management Commentary
Management commentary is limited to the announcement of the pricing and the expectation of listing on the NASDAQ Capital Market. The filing does not provide specific forward-looking guidance on revenue or profitability, nor does it detail specific risks or contingencies beyond the standard closing conditions of the offering.
Investor Verification Checklist
- Verify the final closing date of the offering (expected November 6, 2017) and the actual net proceeds received.
- Confirm the exact number of shares issued versus warrants exercised post-closing.
- Review the Company's subsequent filings (e.g., 10-Q or 10-K) for updated cash position and burn rate following the capital raise.
- Monitor the trading volume and price stability of the "NAOV" ticker on the NASDAQ Capital Market.